Literature DB >> 19955404

Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning.

Yuting Li1, Haohong Li, Xing Liu, Guobin Bao, Yezheng Tao, Ziyan Wu, Peng Xia, Chunfu Wu, Baoming Li, Lan Ma.   

Abstract

Beta-arrestins, key regulators of receptor signaling, are highly expressed in the central nervous system, but their roles in brain physiology are largely unknown. Here we show that beta-arrestin-2 is critically involved in the formation of associative fear memory and amygdalar synaptic plasticity. In response to fear conditioning, beta-arrestin-2 translocates to amygdalar membrane where it interacts with PDE-4, a cAMP-degrading enzyme, to inhibit PKA activation. Arrb2(-/-) mice exhibit impaired conditioned fear memory and long-term potentiation at the lateral amygdalar synapses. Moreover, expression of the beta-arrestin-2 in the lateral amygdala of Arrb2(-/-) mice, but not its mutant form that is incapable of binding PDE-4, restores basal PKA activity and rescues conditioned fear memory. Taken together, our data demonstrate that the feedback regulation of amygdalar PKA activation by beta-arrestin-2 and PDE-4 complex is critical for the formation of conditioned fear memory.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955404      PMCID: PMC2799795          DOI: 10.1073/pnas.0906941106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Activation of ERK/MAP kinase in the amygdala is required for memory consolidation of pavlovian fear conditioning.

Authors:  G E Schafe; C M Atkins; M W Swank; E P Bauer; J D Sweatt; J E LeDoux
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 2.  Neurobiology of Pavlovian fear conditioning.

Authors:  S Maren
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

3.  Both protein kinase A and mitogen-activated protein kinase are required in the amygdala for the macromolecular synthesis-dependent late phase of long-term potentiation.

Authors:  Y Y Huang; K C Martin; E R Kandel
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

4.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  Memory consolidation of auditory pavlovian fear conditioning requires protein synthesis and protein kinase A in the amygdala.

Authors:  G E Schafe; J E LeDoux
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala.

Authors:  C H Lin; S H Yeh; C H Lin; K T Lu; T H Leu; W C Chang; P W Gean
Journal:  Neuron       Date:  2001-09-13       Impact factor: 17.173

7.  The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.

Authors:  Jennifer C Roberts; Charlie Reavill; Simon Z East; Paul J Harrison; Sara Patel; Carol Routledge; Ronald A Leslie
Journal:  Brain Res       Date:  2002-04-26       Impact factor: 3.252

8.  Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance.

Authors:  Bing Luan; Jian Zhao; Haiya Wu; Baoyu Duan; Guangwen Shu; Xiaoying Wang; Dangsheng Li; Weiping Jia; Jiuhong Kang; Gang Pei
Journal:  Nature       Date:  2009-02-26       Impact factor: 49.962

9.  Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins.

Authors:  Stephen J Perry; George S Baillie; Trudy A Kohout; Ian McPhee; Maria M Magiera; Kok Long Ang; William E Miller; Alison J McLean; Marco Conti; Miles D Houslay; Robert J Lefkowitz
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

10.  beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.

Authors:  George S Baillie; Arvind Sood; Ian McPhee; Irene Gall; Stephen J Perry; Robert J Lefkowitz; Miles D Houslay
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more
  15 in total

Review 1.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

2.  Compartmentalized PDE4A5 Signaling Impairs Hippocampal Synaptic Plasticity and Long-Term Memory.

Authors:  Robbert Havekes; Alan J Park; Rosa E Tolentino; Vibeke M Bruinenberg; Jennifer C Tudor; Yool Lee; Rolf T Hansen; Leonardo A Guercio; Edward Linton; Susana R Neves-Zaph; Peter Meerlo; George S Baillie; Miles D Houslay; Ted Abel
Journal:  J Neurosci       Date:  2016-08-24       Impact factor: 6.167

Review 3.  Custom-designed proteins as novel therapeutic tools? The case of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Expert Rev Mol Med       Date:  2010-04-23       Impact factor: 5.600

4.  Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear.

Authors:  Ning Chai; Jian-Feng Liu; Yan-Xue Xue; Chang Yang; Wei Yan; Hui-Min Wang; Yi-Xiao Luo; Hai-Shui Shi; Ji-Shi Wang; Yan-Ping Bao; Shi-Qiu Meng; Zeng-Bo Ding; Xue-Yi Wang; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2014-02-19       Impact factor: 7.853

5.  Lack of the presynaptic RhoGAP protein oligophrenin1 leads to cognitive disabilities through dysregulation of the cAMP/PKA signalling pathway.

Authors:  Malik Khelfaoui; Frédéric Gambino; Xander Houbaert; Bruno Ragazzon; Christian Müller; Mario Carta; Frédéric Lanore; Bettadapura N Srikumar; Philippe Gastrein; Marilyn Lepleux; Chun-Lei Zhang; Marie Kneib; Bernard Poulain; Sophie Reibel-Foisset; Nicolas Vitale; Jamel Chelly; Pierre Billuart; Andreas Lüthi; Yann Humeau
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

Review 6.  β-Arrestins as potential therapeutic targets for Alzheimer's disease.

Authors:  Teng Jiang; Jin-Tai Yu; Meng-Shan Tan; Xi-Chen Zhu; Lan Tan
Journal:  Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.590

7.  RGS6 Mediates Effects of Voluntary Running on Adult Hippocampal Neurogenesis.

Authors:  Yu Gao; Minjie Shen; Jose Carlos Gonzalez; Qiping Dong; Sudharsan Kannan; Johnson T Hoang; Brian E Eisinger; Jyotsna Pandey; Sahar Javadi; Qiang Chang; Daifeng Wang; Linda Overstreet-Wadiche; Xinyu Zhao
Journal:  Cell Rep       Date:  2020-08-04       Impact factor: 9.423

8.  Identification of cytosolic phosphodiesterases in the erythrocyte: a possible role for PDE5.

Authors:  Shaquria P Adderley; Kelly M Thuet; Meera Sridharan; Elizabeth A Bowles; Alan H Stephenson; Mary L Ellsworth; Randy S Sprague
Journal:  Med Sci Monit       Date:  2011-05

9.  Specific Inhibition of Phosphodiesterase-4B Results in Anxiolysis and Facilitates Memory Acquisition.

Authors:  Alexander McGirr; Tatiana V Lipina; Ho-Suk Mun; John Georgiou; Ahmed H Al-Amri; Enoch Ng; Dongxu Zhai; Christina Elliott; Ryan T Cameron; Jonathan G L Mullins; Fang Liu; George S Baillie; Steven J Clapcote; John C Roder
Journal:  Neuropsychopharmacology       Date:  2015-08-14       Impact factor: 7.853

10.  β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice.

Authors:  Mee Jung Ko; Terrance Chiang; Arbaaz A Mukadam; Grace E Mulia; Anna M Gutridge; Angel Lin; Julia A Chester; Richard M van Rijn
Journal:  Sci Signal       Date:  2021-08-03       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.